Main Topics

Introduction to Genetics |
Basic principles for the non-geneticist |
Next generation sequencing: strategies for genetic testing |
Technical aspects of reproductive genetics (Methods of PGS, PGD, Prenatal) |
Carrier screening of recessive disease: Universal screening |
PGD and PGS: State-of-the-Art |
Development and current best practice for translocations |
Single gene diagnosis and aneuploidy detection using karyomapping |
Clinically evaluating NGS and its extra information |
PGS for advanced maternal age |
The clinical value of Preimplantation Genetic Screening (PGS) |
Management of PGS treatment embryo: timing, technology, success and cost effectiveness |
Aneuploidy in embryos: variability between centers, between patients and between cycles of the same patients |
Debate: Is it now unethical not to screen out an aneuploidy embryo in IVF? |
Prediction of Gamete quality and viability |
Cumulus cell genomics and its predictive value |
Blastocoel analysis for PGS and the potential clinical value of mitochondrial screening assays |
Ultra-sensitive mass spectrometry to look at the proteomic content of the blastocoel fluid with a view to embryo viability assessment |
Update on polar body testing for detection of female meiotic errors |
Non-Invasive Prenatal Testing (NIPT): Current state of the ART |
Introduction of NIPT in clinical practice |
Debate: How should NIPT be used: - As primary screening to all patients - As contingent screening in very high and intermediate risk patients |
Non-Invasive Prenatal Testing (NIPT): Future Perspectives |
Debate: NIPT for microdeletion syndromes Pros Cons |
NIPT for Single-Gene Disorders |
Future development in NIPT |
Chromosomal microarrays (CMA) in Prenatal Diagnosis |
Chromosomal microarrays - how does it work? |
Can CMA replace standard karyotyping? |
Counseling for Variants of Unclear Clinical Significance |
Debate: Would it be ethical not to propose women to undergo invasive testing with CMA? For Against |
Genetics in infertility |
Characterization of the molecular etiology of severe cases of infertility - a must to bring personalized medicine to the field of reproduction |
Carrier screening of genes relevant in infertility, including mutations associated with miscarriage |
Gene therapy in reproductive medicine |
Social and legal aspects |